[1]李文强 贾丽娟 赵锦华 陈鹏 吴雅欣 杨霖崧.巨噬细胞迁移抑制因子基因多态性与颈动脉粥样硬化及斑块易损性的相关性研究[J].卒中与神经疾病杂志,2020,27(05):599-603.[doi:10.3969/j.issn.1007-0478.2020.05.009]
　Li Wenqiang,Jia Lijuan,Zhao Jinhua,et al.The relationship between macrophage migration inhibition factor gene polymorphism and carotid atherosclerosis, vulnerability of carotid plaque[J].Stroke and Nervous Diseases,2020,27(05):599-603.[doi:10.3969/j.issn.1007-0478.2020.05.009]
点击复制

巨噬细胞迁移抑制因子基因多态性与颈动脉粥样硬化及斑块易损性的相关性研究()
分享到：

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第27卷
期数:
2020年05期
页码:
599-603
栏目:
论 著
出版日期:
2020-10-20

文章信息/Info

Title:
The relationship between macrophage migration inhibition factor gene polymorphism and carotid atherosclerosis, vulnerability of carotid plaque
文章编号:
1007-0478(2020)05-0599-05
作者:
李文强 贾丽娟 赵锦华 陈鹏 吴雅欣 杨霖崧
Author(s):
Li Wenqiang;  Jia Lijuan;  Zhao Jinhua;  et al.
Department of Neurology, the First Peoples Hospital of Xianyang, Xianyang Shanxi 712000
关键词:
巨噬细胞迁移抑制因子 基因多态性 颈动脉粥样硬化 斑块易损性
Keywords:
Macrophage migration inhibition factor Gene polymorphism Carotid atherosclerosis Vulnerability of plaque
分类号:
R743.3
DOI:
10.3969/j.issn.1007-0478.2020.05.009
文献标志码:
A
摘要:
目的 探讨巨噬细胞迁移抑制因子(MIF)基因多态性与颈动脉粥样硬化及斑块易损性的关系。方法 收集2018年1月-2019年12月本科收治475例缺血性脑卒中患者纳入研究,根据颈部血管超声表现分为无斑块组(n=107)、稳定斑块组(n=172)和易损斑块组(n=196); 采用ELISA法检测所有入组人员血清MIF水平; 采用聚合酶链反应联合DNA直接测序法检测MIF基因-173G/C位点基因型。结果 稳定斑块组和易损斑块组血清MIF水平均显著高于无斑块组(P均<0.05),易损斑块组血清MIF水平显著高于稳定斑块组(P<0.05); 稳定斑块组和易损斑块组MIF基因-173G/C位点基因型和等位基因频率与无斑块组比较均有明显差异(P均<0.05); 稳定斑块组基因型和等位基因频率与易损斑块组比较均无明显差异(P均>0.05); CC基因型携带者血清MIF水平均显著高于GG和GC基因型携带者(P均<0.05)。校正年龄、性别等参数后-173G/C位点C等位基因携带者颈动脉斑块总体发生风险是T等位基因携带者的2.035倍(95%CI=1.284～3.227,P=0.003)。结论 MIF基因-173G/C位点多态性与颈动脉硬化密切相关,携带C等位基因是颈动脉粥样硬化斑块形成的危险因素,但该位点基因多态性与颈动脉斑块易损性无明确相关性。
Abstract:
ObjectiveTo investigate the relationship between macrophage migration inhibition factor(MIF)gene polymorphism and carotid atherosclerosis, vulnerability of carotid plaque.Methods A total of 475 patients with ischemic stroke hospitalized in our department from January 2018 to December 2019 were recruited in this study. These patients were divided into non-plaque group(107 cases), stable plaque group(172 cases)and vulnerable plaque group(196 cases), according to the manifestations of carotid ultrasonography. ELISA was used to detect serum levels of MIF. Genotype was determined by polymerase chain reaction- direct sequencing for the MIF gene -173G/C polymorphism.Results Serum levels of MIF in stable plaque group and vulnerable plaque group were higher than those in non-plaque group(both P<0.05). Serum level of MIF in vulnerable plaque group was higher than that in stable plaque group(P<0.05). The genotype and allele frequencies of -173G/C in stable plaque group and vulnerable plaque group were significantly different from those in non-plaque group(all P<0.05). There was no significant difference in genotype and allele frequencies of -173G/C between stable plaque group and vulnerable plaque group(both P>0.05). Serum MIF levels of CC genotype carriers were higher than those of CG and GG genotype carriers(both P<0.05). After adjusting risk factors(age, gender, etc), the risk of carotid atherosclerostic plaque in -173G/C C allele carriers was 2.035 times of that in G allele(95%CI=1.284～3.227, P=0.003).Conclusion MIF -173G/C gene polymorphism was associated with carotid atherosclerosis, and the -173G/C C allele might act as a risk factor for carotid atherosclerosis plaque. However, -173G/C gene polymorphism might not be associated with vulnerability of carotid plaque.

参考文献/References:

[1] Qin C,Zhang L,Wang X,et al.Evaluation of carotid plaque neovascularization in patients with coronary heart disease on Contrast-Enhanced ultrasonography[J].J Ultrasound Med,2018,37(4):823-831.
[2] Lechtman E,Balki I,Thomas K,et al.Cost-effectiveness of magnetic resonance carotid plaque imaging for primary stroke prevention in Canada[J].Br J Radiol,2018,91(181):20170518.
[3] Djudjaj S,Martin IV,Buhl EM,et al.Macrophage migration inhibitory factor limits renal inflammation and fibrosis by counteracting tubular cell cycle arrest[J].Journal of the American Society of Nephrology,2017,28(12):3590-3604.
[4] Lin Q,Cai JY,Lu C,et al.Macrophage migration inhibitory factor levels in serum from patients with acute intracerebral hemorrhage: Potential contribution to prognosis[J].Clinica Chimica Acta,2017,472:58-63.
[5] Yen-Chung L,Yung-Chun C,Chih-Peng C,et al.Minocycline suppresses dengue virus replication by down-regulation of macrophage migration inhibitory factor-induced autophagy[J].Antiviral Res,2018,155:28-38.
[6] Qian Z,Li M,Li XM,et al.Circulating MIF levels predict clinical outcomes in patients with ST-Elevation myocardial infarction after percutaneous coronary intervention[J].Canadian Journal of Cardiology,2019,35(10):1366-1376.
[7] 杜培儒,吴伟,侯学荣,等.MIF基因单核苷酸多态性与中国西北地区汉族人群克山病的关联研究[J].中华地方病学杂志,2019,38(5):357-360.
[8] Merchant S,Nadaraj S,Chowdhury D,et al.Macrophage migration inhibitory factor in pediatric patients undergoing surgery for congenital heart repair[J].Molecular Medicine,2008,14(3/4):124-130.
[9] Du GL,Luo JY,Wang DL,et al.MIF gene rs755622 polymorphism positively associated with acute coronary syndrome in Chinese Han population: case-control study[J].Sci Rep,2020,10(1):140.
[10] Luo JY,Rui X,Li XM,et al.MIF gene polymorphism rs755622 is associated with coronary artery disease and severity of coronary lesions in a Chinese kazakh population[J].Medicine,2016,95(4):e2617.
[11] Ji KT,Wang XY,Ji L,et al.Macrophage migration inhibitory factor polymorphism is associated with susceptibility to inflammatory coronary heart disease[J].Biomed Res Int,2015:1-6.
[12] 中华医学会神经病学分会.中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志,2015,48(4):246-257.
[13] 刘燕,刘晓辉,宋艳玲,等.急性脑梗死患者血清Ⅰ型胶原羧基末端肽改变及其与颈动脉粥样硬化斑块的关系[J].心肺血管病杂志,2018,37(1): 39-41+45.
[14] Lan MY,Yung-Yee C,Wei-Hsi C,et al.Association between MIF gene polymorphisms and carotid artery atherosclerosis[J].Biochem Biophys Res Commun,2013,435(2):319-322.
[15] 王三敏,伏兵,佘瑞芳,等.血清同型半胱氨酸和巨噬细胞移动抑制因子水平与颈动脉粥样硬化相关性研究[J].重庆医学,2014,43(2):182-184.
[16] 代传芬,刘兴德,罗惠兰,等.MIF及其基因-173G/C多态性与飞行员动脉粥样硬化危险因素的相关性研究[J].解放军医学杂志,2016,41(2):153-157.
[17] Herder C,Illig T,Baumert J,et al.Macrophage migration inhibitory factor(MIF)and risk for coronary heart disease: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002[J].Atherosclerosis,2008,200(2):380-388.

备注/Memo

备注/Memo:
作者单位:712000 陕西省咸阳市第一人民医院神经内科[李文强 贾丽娟(通信作者)赵锦华 陈鹏 吴雅欣 杨霖崧]
更新日期/Last Update: 2020-10-20